Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
¹ÚÁö¼÷, ¼ÁöÇö, À±Èñ»ó,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁö¼÷ ( Park Ji-Sook )
Gyeongsang National University School of Medicine Department of Pediatrics
¼ÁöÇö ( Seo Ji-Hyun )
Gyeongsang National University School of Medicine Department of Pediatrics
À±Èñ»ó ( Youn Hee-Shang )
Gyeongsang National University School of Medicine Department of Pediatrics
KMID : 0816120130160010022
Abstract
The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.
Å°¿öµå
Obesity;Microbiota;Non-alcoholic fatty liver disease
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸